Aliphatic propargylamines as symptomatic and neuroprotective treatments for neurodegenerative diseases (Q34802137)

4 August 2017

1 reference

title

Aliphatic propargylamines as symptomatic and neuroprotective treatments for neurodegenerative diseases (English)

1 reference

4 August 2017

1 reference

Berry MD

1

1 reference

4 August 2017

Boulton AA

series ordinal

2

1 reference

4 August 2017

publication date

1 September 2002

1 reference

Neurotoxicology and Teratology

4 August 2017

published in

1 reference

4 August 2017

volume

24

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

667-673

1 reference

DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

N8-acetyl spermidine protects rat cerebellar granule cells from low K+-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Programmed cell death: does it play a role in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

PET studies of functional compensation in a primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

p53 involves cytosine arabinoside-induced apoptosis in cultured cerebellar granule neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Involvement of p53 in DNA strand break-induced apoptosis in postmitotic CNS neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

TUNEL-Positive Ganglion Cells in Human Primary Open-angle Glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Neurodegeneration in Alzheimer disease. Is apoptosis involved?

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Apoptosis and expression of DNA repair proteins in ischaemic brain injury in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Histochemical detection of apoptosis in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

(-)-Deprenyl alters the survival of adult murine facial motoneurons after axotomy: increases in vulnerable C57BL strain but decreases in motor neuron degeneration mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

R-deprenyl and R-2-heptyl-N-methylpropargylamine prevent apoptosis in cerebellar granule neurons induced by cytosine arabinoside but not low extracellular potassium.

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models.

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase.

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Evidence for apoptotic cell death in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Immunohistochemical evidence for apoptosis in Alzheimerʼs disease

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

DNA End Labeling (TUNEL) in Huntington's Disease and Other Neuropathological Conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Apoptosis, retinitis pigmentosa, and degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2802%2900217-9

7 January 2021

10.1016/S0892-0362(02)00217-9

Identifiers

DOI

1 reference

4 August 2017

1 reference